Transcription factor NF-E2-related factor 2 (Nrf2) is important for cell protection against chemical-induced oxidative stress. Previously, we have reported that in PC12 cells, Nrf2 can be triggered by deltamethrin (DM), a commonly used pyrethroid insecticide. Molecular mechanisms behind Nrf2 activation by DM are still unclear. Here we studied the effects of cell glutathione (GSH) depletion on Nrf2 activation by DM. We found that DM enhanced Nrf2 expression at the mRNA and protein levels and increased nuclear Nrf2 levels. Activation of Nrf2 was associated with activation of its downstream targets, such as heme oxygenase-1 (HO-1) and glutamate cysteine ligase catalytic subunit (GCLC). In contrast, DL-buthionine-[S,R]-sulfoximine (BSO), a known GSH-depleting agent, did not increase Nrf2 protein expression or cause its nuclear accumulation. However, pre-treatment with BSO triggered mRNA expression of HO-1 and GCLC. Furthermore, BSO pre-treatment suppressed DM-induced Nrf2 upregulation and activation and lowered mRNA expression of HO-1 and GCLC upon DM treatment. These data demonstrate that GSH depletion is not necessary for the activation of Nrf2/ARE by DM in PC12 cells, and that GCLC and HO-1 expression can increase through other signalling pathways.
Pyrethroids are widely used agricultural pesticides because of their effectiveness as nerve poisons and their low environmental impact (1) . The most effective of the group is deltamethrin [(S)a-cyano-3-phenoxybenzyl-(1R)-cis-3-(2.2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate, DM], which causes neurological disorders (choreoathetosis with salivation, also known as CS syndrome) (1, 2) .
Transcription factor NF-E2-related factor 2 (Nrf2), a part of the Cap'n'Collar family of basic leucine zipper (bZIP) proteins, plays a key role in the activation of multiple genes encoding antioxidants and phase II drug-metabolising enzymes through antioxidant response elements (AREs) (3, 4) . AREs are located in the 5'-fl anking region of various genes engaged in the cellular protection against oxidative stress, such as the glutamate cysteine ligase modifi er subunit (GCLM) (5-7), heme oxygenase 1 (HO-1) (8) (9) (10) (11) , and the glutamate cysteine ligase catalytic subunit (GCLC).
Glutamate cysteine ligase (GCL) is the first enzyme in the pathway of glutathione (GSH) synthesis. GCL is a heterodimeric enzyme containing a catalytic subunit (GCLC), which is capable of catalysis alone, and a modifi er subunit (GCLM), which increases the catalytic effi ciency of GCLC and reduces feedback inhibition by GSH. Synchronised induction of these enzymes should protect the cell against the adverse effects of reactive oxygen species (ROS).
We have previously reported that DM enhances the release of free radicals and nuclear translocation of the stress response transcription factor Nrf2 in rat brain and PC12 cells in vitro (12, 13) . Several mechanisms, including oxidation of redox-sensitive cysteines in Keap1 (14) , ubiquitination (15, 16) , phosphorylation (17, 18) , and nuclear shuttling (19, 20) , have been proposed to regulate Nrf2 activity. In spite of their differences, all of these mechanisms seem to involve Keap1 protein-mediated recognition and transduction of signals for Nrf2 activation. A study by Goldring et al. (21) has shown that diethylmaleate (DEM), a GSHdepleting agent, can release Nrf2 in vivo, permitting its nuclear translocation and coordinated upregulation of ARE-driven defence genes. These fi ndings imply that a relationship between nuclear translocation of Nrf2 and GSH level depends on whether exposure involves a substance with inherent protein reactivity.
The rationale for testing whether GSH depletion affects Nrf2 induction by DM is to see if DM triggers Nrf2 activation through GSH depletion or the process involves other chemical stressors. With this in mind, we studied the effects of GSH depletion on Nrf2 activated by DM in differentiated PC12 cells, a rat adrenal pheochromocytoma cell line with the phenotypic properties of sympathetic neurons, which are more susceptible to oxidative stress than undifferentiated cells (22) . 
MATERIALS AND METHODS

Reagents and instruments
Culture and treatment of PC12 cells
Differentiated PC12 cells were obtained from the Institute of Cell Biology of the Chinese Academy of Sciences (Shanghai, China). They were cultivated in DMEM supplemented with 10 % heat-inactivated foetal bovine serum at 37 °C in a humidified atmosphere consisting of 95 % air and 5 % CO 2 . The medium was replaced every other day, and cells plated at a density adjusted to the experimental needs. After an incubation period of 24 h, cells were transferred to a serum-free culture medium and treated.
Based on previous results (23, 24) , in this experiment we used BSO in the concentration of 500 μmol L -1 reconstituted with DMSO in the fi nal concentration not over 0.1 % so as not to infl uence the evaluated parameters (data not shown).
PC12 cells were incubated with 500 μmol L -1 BSO for 16 h immediately after they were transferred to a serum-free culture medium. Negative control cultures were not exposed to BSO, and exposure to BSO did not affect cell viability (data not shown).
Following BSO exposure the cells were treated with 10 μmol L -1 DM for 1 h.
Semiquantitative reverse transcription polymerase chain reaction (RT-PCR) analysis
Reverse transcription PCR was done as reported in our earlier paper (25) 
Immunocytochemical detection of HO-1
Protein expression of HO-1 was detected by immunocytochemistry. PC12 cells were cultivated on poly-L-lysine-coated coverslips as described by Deptala et al. (26) with slight modifi cations. After the treatment, the cells were rinsed with PBS twice and fi xed in 95 % ethanol at -20 °C for 15 min. After a second wash in PBS, the fi xed cells were permeabilised in 0.2 % Triton X-100 in PBS for 15 min, rinsed with pure PBS and blocked with normal goat serum at room temperature for 30 min. The cells were fi rst treated with an anti-HO-1 antibody (in the dilution of 1:50) at 4 °C for 18 h and then incubated with FITC-labelled goat anti-rabbit IgG (H+L) at 37 °C for 30 min.
After the cells were rinsed with PBS, microscope slides were prepared. We used a 50 % glycerin buffer solution as a mounting medium. Slides were examined on a laser scanning confocal microscope equipped with a UPLAPO 100x oil immersion objective lens (Fluoview FV500, Olympus, Tokyo, Japan). The imaging settings were optimised to ensure signal detection and consistency of images. Imaging data were processed using Fluoview version 4.3.53 and analysed using image-Pro Plus version 5 (Media Cyberbetics Inc., Bethesda, MD, USA) and Adobe Photoshop 8.0 (Adobe Inc., San Jose, CA, USA). The images were analysed by an investigator blind to this treatment protocol. HO-1 expression was checked by measuring whole-cell FITC signal intensity.
Preparation of cytosolic and nuclear extracts
Cytosolic and nuclear extracts were isolated according to Schreiber et al. (27) with some modifi cations. After rinsing with cold PBS, cells were resuspended in cold lysis buffer A (20 mmol L
PMSF, 0.5 mg mL -1 benzamidine, 0.1 mg mL -1 leupeptin, and 1.2 mg mL -1 aprotinin). They were incubated on ice for 15 min, after which 7.5 μL of 10 % NP-40 detergent was added. Afterwards the cells were intensively stirred in a vortex mixer for 10 s. The homogenate was centrifuged at 16,000 g for 50 s, and the supernatant was used as the cytosolic extract. The nuclear pellet was resuspended in cold extraction buffer B (20 mmol L -1 HEPES pH 8.0, aprotinin, and 20 % glycerol). All protein fractions were stored at -70 °C until used, and protein concentrations were determined with the Bradford method, using bovine serum albumin as the standard.
Table 1 Primer sequence used in RT-PCR analysis
Gene name Primer sequence for PCR Size of expected production / bp
Nrf2 5'-CCATTTACGGAGACCCAC-3' 448 3'-CTTATTTCAACGGCGAGT-5' HO-1 5'-ACAGAAGAGGCTAAGACCG-3' 441 3'-TTACCTTCCTCTACGGAC-5' γ-GCLC 5'-CATCTACCACGCAGTCAA-3' 351 3'-GCTATTGAAGTAAAGGGTC-5' γ-GCLM 5'-ACATTGAAGCCCAGGAGT-3' 266 3'-ACACCACCAAACCGTTAC-5' GAPDH 5'-AAATGGGTGATGCTGGTG-3' 188 3'-TGAGCGAGTTCTAACAGTCG-5' bp -base pairs 1 mmol L -1 EDTA, 1.5 mmol L -1 MgCl 2 , 10 mmol L -1 KCl, 1 mmol L -1 DTT, 1 mmol L -1 sodium orthovanadate, 1 mmol L -1 NaF, 1 mmol L -1 PMSF,
Western blotting analysis
Protein samples were resolved on 10 % SDSpolyacrylamide gels and were transferred to nitrocellulose membranes. Membranes were blocked in Tris-buffered saline (TBS) with 0.1% Tween-20, and 5 % nonfat dry milk for 1 h. After that they were incubated overnight with primary antibodies diluted in the identical buffer. Nrf2 was used in the dilution of 1:500; and GAPDH in the dilution of 1:8,000. After the washing with 0.1 % Tween-20 in TBS, the membranes were incubated with peroxidase-conjugated secondary antibodies for 1 h and then rinsed and developed using the ECL chemiluminescent detection system. Blots were then visualised with X-ray fi lms. The results were analysed using the Bandscan 4.3 software. Densitometry was normalised against the signal obtained from coincubation with anti-GAPDH.
Measurement of the reduced GSH content
The reduced GSH content was measured using reversed-phase high performance liquid chromatography with o-phthalaldehyde precolumn derivatisation as described elsewhere (13, 28) .
Statistical analysis
Data bars correspond to mean values ± SD of minimum three independent experiments. The results were evaluated using SPSS for Windows (version 18.0, Chicago, IL, USA). Differences between the groups were assessed using one-way analysis of variance (ANOVA). If the F values were signifi cant, LSD post hoc tests were employed for multiple comparisons between the groups. The value of P≤0.05 was deemed statistically signifi cant.
RESULTS
Effects of DM on the Nrf2/ARE pathway
Using cytosolic and nuclear fractions of PC12 cells to establish the relative distribution of Nrf2 we found that Nrf2 migrated with a molecular weight of around 100 kDa. Such an atypical migration was previously observed in human neuroblastoma cells (29) .
As proposed by Shukla et al. (30) , samples from the nuclear fraction resolved on parallel gels were stained with Coomassie brilliant blue for protein visualisation, and analysed with Western blot to detect the target protein. Save for the evidently increased signal intensity in the 100 kDa molecular weight fraction, the protein distribution pattern in PC12 cells treated with DM or BSO resembled that of untreated cells. This suggests that the nuclear protein loaded in the gel lanes was of the same amount (data not shown), and that the 100 kDa band corresponded to the specifi c recognition of Nrf2 antibodies. Protein expression of Nrf2 increased after DM treatment both in the nuclear and the cytosolic fractions compared to control PC12 cells (Figure 1 ). This implies that DM may induce Nrf2 expression and facilitate Nrf2 activation. To establish the effects of DM on Nrf2 gene transcription, we analysed Nrf2 mRNA expression using RT-PCR. The data showed that the mRNA level of Nrf2 was also elevated upon DM treatment (Figure 2) . The enhanced expression and nuclear translocation of Nrf2 indicates that the expression of antioxidant and phase II detoxifi cation genes might also be enhanced through Nrf2-mediated transcriptional activation of ARE-containing genes. To verify this assumption, we assessed the mRNA levels of HO-1 and GCLC, two acknowledged Nrf2-targeted antioxidant genes, and observed that the mRNA level of HO-1 in PC12 cells indeed increased 1.7 fold by DM treatment (Figure 2 ). This increase in HO-1 mRNA expression was linked with an even greater, 6.4-fold increase in its protein expression (Figure 3 ) in respect to untreated cells. In PC12 cells treated with DM, the GCLC mRNA level also increased (Figure 2 ) compared to control. In summary, our data show that Nrf2 activation by DM induced the expression of several Nrf2-regulated genes in PC12 cells. 
Figure 2 Effect of BSO on DM-induced expression of
Figure 3 E f f e c t o f B S O o n D M -i n c re a s e d H O -1 immunofl uorescent intensity. PC12 cells were grown on cover slips and incubated with or without
Effects of BSO pre-treatment on the nuclear translocation of Nrf2 induced by DM
GSH depletion triggers oxidative stress and is considered a major activator of the Nrf2-ARE pathway. To further clarify the requirement of GSH depletion in Nrf2 activation, we pre-treated PC12 cells with BSO, a known GSH-depleting agent, and then with DM to assess changes in the expression and subcellular distribution of Nrf2. Compared to vehicle-treated controls, cells treated with BSO alone showed no change in Nrf2 expression or its distribution ( Figure  1 ). However, compared to the DM-treated cells, cells pre-treated with BSO had a lower Nrf2 protein level in both the nucleus and the cytosol (Figure1), indicating that BSO inhibited DM-induced Nrf2 activation and translocation.
Effects of BSO pre-treatment on DM-increased mRNA expression of GCS, HO-1, and Nrf2
We then measured the effects of BSO pre-treatment on the expression of Nrf2 and Nrf2-regulated genes HO-1, GCLC, and GCLM to explain the molecular mechanism behind Nrf2 activation by DM. The mRNA levels of HO-1, GCLC, and GCLM were measured in PC12 cells treated with DM or BSO. Cells treated with BSO alone showed increased GCLC and HO-1 mRNA expression, but decreased GCLM mRNA expression compared to vehicle-treated controls. However, Nrf2 mRNA expression was unchanged, indicating that BSO promotes gene expression in an Nrf2-independent manner. The alternative explanation is that GSH depletion can directly enhance mRNA expression of GCLC and HO-1. When compared to the DM-treated cells, cells pre-treated with BSO before DM treatment had lower GCS-h and HO-1 mRNA expression and a modest increase in the Nrf2 mRNA level (Figure 2) , suggesting that BSO pre-treatment could suppress DM-induced upregulation of GCLC and HO-1 mRNA.
Effects of BSO pre-treatment on DM-increased protein expression of HO-1
Both BSO alone and DM alone increased HO-1 protein expression ( Figure 3B ). In cells pre-treated with BSO for 16 h followed by DM exposure, HO-1 mRNA expression was slightly lower than in cells treated with DM or BSO alone. Surprisingly, BSO did not suppress DM-induced upregulation of the HO-1 protein. On the contrary, a slight increase was observed ( Figure 3B) , indicating a synergistic effect of BSO and DM.
Effect of BSO pre-treatment on the GSH content in PC12 cells treated with DM
DM alone had no effect on the GSH content, whereas BSO alone and BSO+DM decreased it significantly by 44.0 % and 68.1 %, respectively (Figure 4) . However, the difference in GSH levels between BSO and BSO+DM treatment was not signifi cant (Figure 4 ).
DISCUSSION
Several studies have shown that oxidants and xenobiotics might activate inactive Nrf2 by facilitating its translocation from the cytoplasmic compartment towards the nucleus (31, 32) . To establish whether DM controls Nrf2 activity in such a way, we determined Nrf2 levels in subcellular fractions after DM treatment. The original hypothesis has been that Nrf2 level in the cytosolic fraction would decrease, with a simultaneous increase in the nuclear fraction. However, DM treatment increased Nrf2 protein levels in both the cytosolic and the nuclear fractions at the same time (Figure 1 ). This DM-induced Nrf2 upregulation was also observed at the mRNA level by RT-PCR, indicating that increased Nrf2 protein level in DM-treated PC12 cells was, at least to some extent, caused by enhanced Nrf2 gene transcription. Our fi ndings undoubtedly confi rm the association between DM exposure and elevated cellular and nuclear accumulation of Nrf2, which consequently promotes the expression of Nrf2-regulated oxidative stress response genes (Figure 1) .
Generally, in in vitro toxicology studies, chemical treatment in culture media should be conducted under serum-free conditions. This is why we transferred the PC12 cells after initial 24-h incubation to a serum-free culture medium for treatment. How serum deprivation affected Nrf2 protein expression or nuclear accumulation was unclear. Nevertheless, the addition of DM or BSO into serum-free culture medium signifi cantly affected Nrf2 protein expression and nuclear accumulation compared to control.
DM treatment had no effect on GSH content, whereas BSO alone and BSO+DM had a similar signifi cantly decreasing effect on (Figure 4) . BSO was used to see whether nuclear Nrf2 level increased by DM in PC12 cells were mediated by GSH. In contrast to DM, BSO did not signifi cantly increase nuclear Nrf2, which suggests that GSH depletion alone could not cause Nrf2 upregulation or activation. It is known that BSO irreversibly binds GCLC and is not likely to produce ROS or chemically reactive metabolites that can modify cellular macromolecules (33) . In contrast, DM requires metabolism to induce extensive covalent modifi cation of cellular proteins. Goldring et al. (21) have proposed that Nrf2 may be activated in mice liver by its dissociation from the cytoplasmic inhibitor Keap1 either through a redoxsensitive mechanism related to GSH depletion or through Michael addition (21) .
However, the results we obtained with BSO suggest that lowering the GSH level did not induce nuclear translocation of Nrf2 ( Figure 1 and Figure 4) . Instead, BSO pre-treatment inhibited Nrf2 activation and nuclear translocation provoked by DM (Figure1), suggesting a mechanism of Nrf2 activation independent of GSH depletion. Therefore, a more direct interaction may be involved, probably related to chemical modifi cation of Nrf2 or Keap1 potentiated by the earlier loss of GSH.
Nguyen et al. (32) identifi ed nine distinct classes of Nrf2 inducers that share several characteristics: a) all are chemically reactive; b) most are electrophiles; c) many are substrates for GSH S-transferases; and d) all can covalently modify sulphydryl groups by alkylation, oxidation, or reduction. So far, various mechanisms have been suggested to explain Nrf2 activation, including oxidation of redox-sensitive cysteine residues in Keap1, phosphorylation of Nrf2, and covalent adduct formation with protein stabilisation (31) .
The fi ndings of Goldring et al. (21) imply that changes in the Nrf2 system may not depend on toxicity related to changes in the GSH level, but could be associated with the formation of chemically reactive or electrophilic species. Indeed, Zhang et al. (34) have found that 4-hydroxynoneneal, a lipid peroxidation product, induces Nrf2 at sub-toxic concentrations. This fi nding supports the idea that chemically reactive electrophilic species can activate Nrf2, and that Keap1 degradation is probably not required for Nrf2 translocation.
In our study, Nrf2 mRNA expression was not suppressed by BSO+DM. However, BSO pre-treatment did inhibit its DM-mediated increase in protein level in the cytoplasm and the nucleus. This inhibitory effect of BSO on Nrf2 activation and translocation may be mediated by the effects of BSO on ROS accumulation. Earlier fi ndings in DM-exposed PC12 cells showed that ROS mediated nuclear accumulation of Nrf2 (25) . Moreover, increased nuclear accumulation of Nrf2 after DM exposure was associated with the production of free radicals in rat brain (12) . Pre-treatment with BSO for 16 h significantly reduced DM-induced increase in DCF fluorescence intensity (by about 40 %), indicating that BSO could attenuate ROS production induced by DM (35) . Taken together, these data suggest that Nrf2 activation may rely on chemically reactive metabolites generated through a DM-mediated protein modifi cation. Therefore, BSO pre-treatment may inhibit DM-induced Nrf2 activation and translocation by decreasing ROS levels in PC12 cells.
Induction of HO-1 by Nrf2 through ARE has recently been established using Nrf2 dominantnegative mutants (Nrf2M) (36) . Recent experiments (6, (37) (38) (39) (40) (41) have also shown that Nrf2 takes place in both basal and induced expression of multiple AREcontaining genes that encode detoxifi cation enzymes and human GCLC and GCLM.
It has already been established that BSO, an inhibitor of gamma-glutamylcysteine synthetase and the rate-limiting enzyme in the biosynthesis of GSH, increases HO-1 enzyme activity, HO-1 protein expression, and HO-1 mRNA expression in rat brain and liver cell lines (42) (43) (44) (45) (46) . However, our results have demonstrated that BSO can induce HO-1 and GCLC mRNA expression without affecting Nrf2 translocation ( Figure 1 and Figure 2) , precluding therefore the involvement of Nrf2-ARE signalling. HO-1 and GCLC expression is, in fact, altered by redox-sensitive transcription factors that recognise particular binding sites within the promoter and distal enhancer regions of these genes (3, 47) . These transcription factors include Fos/Jun activator protein-1 (AP-1), nuclear factor-κB (NF-κB), and the newly recognised Nrf2 proteins (48, 49) . Additionally, HO-1 is quickly upregulated by oxidative and nitrosative stress and by GSH depletion as well (50) (51) (52) .
In a study with rat lung epithelial L2 cells exposed to oxidative stress or GSH depletion, Tian et al. (53) have found evidence for enhanced transcription of the regulatory subunit of gamma-glutamylcysteine synthetase. GCS mRNA expression also increased in rat myocardium, although GCS activity is suppressed by BSO (54). Urata et al. (55) have also found that BSO can trigger the transcription factor NF-κB. We speculate that HO-1 and GCLC upregulation induced by BSO might be mediated by Fos/Jun (AP-1) or NF-κB in PC12 cells. Thus, GCS and HO-1 induction by DM alone or by BSO alone may follow different signalling pathways. We also found that BSO pretreatment increased HO-1 protein upregulation by DM. It is possible that this upregulation may involve transcription factors other than Nrf2, such as Fos/Jun (AP-1) or NF-κB. GCS subunits seem ro follow different regulation pathways. However, Gipp et al. (56) did not fi nd a correlation between the steady-state mRNA levels of the two GCS subunits. In our study, the expression of GCS subunits was signifi cantly affected by DM, and GCLC mRNA levels increased (Figure 2 ), whereas GCLM mRNA levels did not change (Figure 2 ). This discrepancy might be due to a different response to DM exposure. An additional factor that complicates characterising DM-related decrease in ARE-dependent gene transcription is the effect of other interacting partners on Nrf2, because Nrf2 makes heterodimers with other bZip proteins, for instance the Jun/Fos family, Fra, small Maf, and ATF4 proteins (3, 40, 57, 58) .
Partnering factors could infl uence Nrf2-dependent gene expression, either through stimulating or reducing it. It has not yet been established whether relative proportions of these partner proteins change in DMtreated PC12 cells. It will be interesting to investigate possible DM-associated changes in these factors, above all the Jun/Fos family members and their effects on ARE-mediated gene transcription.
In conclusion, this study has demonstrated that DM can induce Nrf2 nuclear accumulation. Depletion of GSH does not seem necessary for Nrf2 activation. Our results suggest that Nrf2 activation may rely on chemically reactive metabolites derived from covalently modifi ed intracellular molecules that are altered by the highly reactive DM. These data also suggest that GCS and HO-1 induction by DM and BSO follows different signalling pathways.
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